INFLAMMATION
AND FIBROSIS

ARE DESTROYING YOUR
PATIENTS’ KIDNEYS

Disrupt the current thinking about CKD progression in T2D

You’ve controlled their HbA1c and blood pressure. But patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) are still at risk from the effects of unaddressed inflammation and fibrosis in the kidneys, which include: CKD progression, end-stage kidney disease, and cardiovascular events.1-3

There are 3 main categories of drivers of CKD progression, including inflammation and fibrosis1
Learn More
Watch how inflammation and fibrosis are triggered by MR overactivation
Watch Video

Don’t miss the latest information about CKD in T2D

Sign Up for Updates

References:

MR: mineralocorticoid receptor.